| 1 |
34199777 | Endothelin-1 as a Mediator of Heme Oxygenase-1-Induced Stemness in Colorectal Cancer: Influence of p53. | 2021 Jun 4 |
1 |
| 2 |
32343134 | Characterization of Critical Residues in the Extracellular and Transmembrane Domains of the Endothelin Type B Receptor for Propagation of the Endothelin-1 Signal. | 2020 May 12 |
2 |
| 3 |
32561219 | Endothelin receptor antagonists alleviate blood-brain barrier disruption and cerebral edema in a mouse model of traumatic brain injury: A comparison between bosentan and ambrisentan. | 2020 Sep 15 |
1 |
| 4 |
28401480 | Target-Mediated Drug Disposition Pharmacokinetic-Pharmacodynamic Model of Bosentan and Endothelin-1. | 2017 Dec |
2 |
| 5 |
26861196 | Neuropathic pain induced by spinal cord injury: Role of endothelin ETA and ETB receptors. | 2016 Mar 23 |
1 |
| 6 |
27534881 | Endothelin research and the discovery of macitentan for the treatment of pulmonary arterial hypertension. | 2016 Oct 1 |
1 |
| 7 |
25966344 | Endothelin receptors and their antagonists. | 2015 Mar |
1 |
| 8 |
26526351 | Endothelin receptor-antagonists suppress lipopolysaccharide-induced cytokine release from alveolar macrophages of non-smokers, smokers and COPD subjects. | 2015 Dec 5 |
1 |
| 9 |
24851934 | Macitentan (Opsumit) for the treatment of pulmonary arterial hypertension. | 2014 Jul |
1 |
| 10 |
23200808 | Bosentan inhibits oxidative and nitrosative stress and rescues occlusive pulmonary hypertension. | 2013 Mar |
1 |
| 11 |
21828025 | Bosentan inhibits cigarette smoke-induced endothelin receptor expression in pulmonary arteries. | 2012 Apr |
1 |
| 12 |
22205719 | Clinical pharmacokinetics and drug-drug interactions of endothelin receptor antagonists in pulmonary arterial hypertension. | 2012 Dec |
1 |
| 13 |
22359440 | Homology modeling, active site prediction, and targeting the anti hypertension activity through molecular docking on endothelin - B receptor domain. | 2012 |
6 |
| 14 |
21132305 | Successful bosentan therapy for pulmonary arterial hypertension associated with hereditary hemorrhagic telangiectasia. | 2011 Mar |
1 |
| 15 |
20698855 | Cigarette smoke exposure up-regulates endothelin receptor B in human pulmonary artery endothelial cells: molecular and functional consequences. | 2010 Dec |
1 |
| 16 |
21081213 | The cardiovascular physiology and pharmacology of endothelin-1. | 2010 |
1 |
| 17 |
19850966 | TNFalpha-induced GM-CSF release from human airway smooth muscle cells depends on activation of an ET-1 autoregulatory positive feedback mechanism. | 2009 Dec |
1 |
| 18 |
18295521 | Inflammatory responses after endothelin B (ETB) receptor activation in human monocytes: new evidence for beneficial anti-inflammatory potency of ETB-receptor antagonism. | 2008 |
2 |
| 19 |
17911460 | Therapeutic challenges for systemic sclerosis: facts and future targets. | 2007 Sep |
1 |
| 20 |
16219361 | Endothelin receptor antagonists. | 2006 Jun |
1 |
| 21 |
16802735 | [The effect of an endothelin receptor antagonist in Eisenmenger syndrome: a single-center experience of 11 patients]. | 2006 May |
1 |
| 22 |
16919005 | Survival in patients with pulmonary arterial hypertension treated with first-line bosentan. | 2006 Sep |
1 |
| 23 |
15902842 | Role of endothelin in fibrosis and anti-fibrotic potential of bosentan. | 2005 |
1 |
| 24 |
16231952 | Risk management strategies in the postmarketing period : safety experience with the US and European bosentan surveillance programmes. | 2005 |
1 |
| 25 |
14748289 | [Therapeutic implications of endothelin antagonists for cardiovascular diseases]. | 2004 Jan |
1 |
| 26 |
15838329 | Pharmacological characterization of YM598, a selective endothelin-A receptor antagonist. | 2004 Nov |
2 |
| 27 |
12509808 | Endothelin B receptors are expressed by astrocytes and regulate astrocyte hypertrophy in the normal and injured CNS. | 2003 Jan 15 |
1 |
| 28 |
12616854 | [New expansion of endothelin research: perspectives for clinical application of endothelin-receptor antagonists]. | 2003 Feb |
1 |
| 29 |
14506620 | Attenuation of renal vasopressin V2 receptor upregulation by bosentan, an ETA/ETB receptor antagonist. | 2003 Sep |
1 |
| 30 |
14727963 | Bosentan. | 2002 |
1 |
| 31 |
10807679 | Reversal of the vasoconstrictor step of hyperacute xenogeneic rejection of the liver by endothelin antagonists. | 2000 May |
1 |
| 32 |
10953665 | [Endothelins and ischemic heart disease]. | 2000 Jan |
1 |
| 33 |
11187978 | The neurogenic vasodilator response to endothelin-1: a study in human skin in vivo. | 2000 Nov |
1 |
| 34 |
10101112 | Cardiovascular and gill microcirculatory effects of endothelin-1 in atlantic cod: evidence for pillar cell contraction | 1999 May |
1 |
| 35 |
9886874 | Endothelin and endothelin antagonists in hypertension. | 1998 Dec |
1 |
| 36 |
9176269 | ET-1 induces mitogenesis in ovine airway smooth muscle cells via ETA and ETB receptors. | 1997 May |
2 |
| 37 |
9380222 | Impaired renal function in obstructive jaundice: roles of the thromboxane and endothelin systems. | 1997 |
1 |
| 38 |
8751489 | Tissue concentrations of endothelins and functional effects of endothelin-receptor activation in human arteries and veins. | 1996 Aug |
1 |
| 39 |
8124808 | Both ETA and ETB receptors mediate contraction to endothelin-1 in human blood vessels. | 1994 Mar |
1 |